IDEAYA Biosciences: A Buying Opportunity After the Pullback, or Priced for Perfection?
IDEAYA Biosciences shares have retreated from recent highs, presenting investors with a dilemma. While long-term performance remains strong, its premium valuation and significant net losses raise questions about whether the current price already reflects its promising pipeline.